Css LLC Sorrento Therapeutics, Inc. Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $9,796 - $18,407	-7,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $15,800 - $38,710	7,900 New	7,900 $18,000
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $59,052 - $138,684	-8,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $24,733 - $51,313	-4,294 Reduced 33.83%	8,400 $57,000
Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $19,781 - $60,336	-3,206 Reduced 20.16%	12,694 $142,000
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $27,507 - $107,484	15,900 New	15,900 $100,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.